|Articles|May 6, 2003
Understanding of CNS pathology important for unraveling pathways of glaucoma progression and identifying new treatments
Ft. Lauderdale-As compelling evidence shows that the pathological process of glaucoma spreads from the retinal ganglion cell to the major vision stations in the brain, future studies need to consider how those downstream changes can be exploited to improve the understanding of glaucomatous disease progression and to develop new therapeutic interventions, said Neeru Gupta, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
3
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5











































.png)


